Inspiration Biopharmaceuticals names John Butler as ceo
Replaces Michael Griffith who takes position of cso
Butler has joined Inspiration from Genzyme, which was acquired by Sanofi in April. While at Genzyme, he was most recently president of the company's rare genetic diseases business. He also led the company's renal, endocrinology, and cardiovascular businesses.
Prior to Genzyme, Butler held sales and marketing positions at Amgen and Hoffmann-La Roche.